| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.2 |